Sawai Bid For Japan’s Kyorin May Be Thwarted By Founding Family
This article was originally published in PharmAsia News
Executive Summary
The attempt by Japan's Sawai Pharmaceutical to acquire Kyorin Holdings appears to be jeopardized, with the founding family saying it would not sell its stake.